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Proliferative activity of nasopharyngeal carcinoma (NPC) using 20 
biopsy cases obtained from southern China were analyzed by 
immunolabelling with the monoclonal antibody of proliferating cell 
nuclear antigen (PCNA), the numbers of interphase silver stained 
nucleolar organizer regions (AgNORs), and mitotic indices. Nucleolar 
organizer regions (NORs) are loops of ribosomal DNA (rDNA) 
occurring in the nucleoli of cells, which transcribe to ribosomal RNA 
(rRNA) and ultimately direct ribosome and protein formation. PCNA 
is a nuclear protein synthesized in the nucleus late in G1 phase, 
peaking during S phase and subsiding during G2 and M phases of the 
cell cycle. These may indicate that PCNA and AgNORs are present at 
different stages of the cell cycle. The authors found that 28% of 
differentiated non-keratinizing carcinoma type of NPC and 18% of 
undifferentiated carcinoma type of NPC were positively stained by 
PCNA. The mean AgNOR counts for differentiated non-keratinizing 
carcinoma type of NPC, and undifferentiated carcinoma type of NPC 
were 1.8 and 1.2, respectively. The mean mitotic counts for 
differentiated non-keratinizing carcinoma type of NPC and 
undifferentiated carcinoma type of NPC were 3.4 and 2.1, 
respectively. Therefore, it is suggested that PCNA labelling 
immunoreactivity may be correlated with AgNORs score and mitotic 
indeces, thus in NPC, these number and size have been regarded as 
markers of cell proliferative ability.
Introduction 
Nasopharyngeal carcinoma (NPC) was first described as a 
neoplasm occurring in the nasopharynx, characterized by 
anaplastic cells surrounding prominent infiltration of lym-
phoid cells, and this tumor has been known as lymphoepi-
thelioma. The nuclear features of the carcinoma cells are 
distinctive with large nuclear and prominent nucleolus. The 
cytoplasmic features of the carcinoma cells are variable, 
and the cellular borders are often indistinct due to fusion of 
cytoplasms. NPC has been confirmed to arise from squa-
mous epithelium by electron microscopical and immuno-
histochemical examination. According to the World Health 
Organization (WHO) classification, NPC can be divided 
into three types as squamous cell carcinoma, differentiated
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non-keratinizing carcinoma, and undifferentiated carci-
noma. 12) 
 The Epstein-Barr virus (EBV) is associated with a vari-
ety of benign and malignant lymphoproliferative disorders, 
most notably infectious B-cell lymphoma and NPC. Malig-
nant tumors primarily arising in the nasopharynx are most 
often carcinoma or malignant lymphoma. Undifferentiated 
NPC is accompanied by prominent lymphocytic infiltration, 
thus, it is often difficult to differentiate from malignant 
lymphomas, especially of the large-cell type. Although 
histochemical diagnosis of NPC has been difficult to differ-
entiate from malignant lymphoma, immunohistochemical 
diagnosis of NPC may be distinguished from malignant 
lymphoma.'- 11. 13. 17) 
 Proliferating cell nuclear antigen (PCNA) was discov-
ered by Miyachi and co-workers') by the use of autoan-
tibodies in the sera of patients with systemic lupus 
erythematous (SLE). A relationship between the PCNA 
value and other cell proliferative activity has been reported 
by many investigators.2.3•'.'S• 16, 18) Thus, the proportion of 
tumor cells with nuclear positivity for PCNA, the quantity 
of interphase nucleolar organizer regions (NORs),'•5.8-1 14) 
and mitotic indeces are linearly related. In this study, we 
examined to assess proliferative activity in differentiated 
non-keratinizing carcinoma type of NPC and undiffer-
entiated carcinoma type of NPC, using following tech-
niques; (1) fraction of immunoreactive for PCNA, (2) 
evaluation of AgNORs, (3) mitotic counting.
Materials and Methods 
The NPC specimens from 20 biopsy cases at the Jinan 
University Hospital in southern China were used. Shanmu-
garatnam and Sobin criteria were applied in assigning the 
diagnosis of NPC to the tissue. These NPC cases were 
divided into two groups as follows: (1) differentiated non-
keratinizing carcinoma, and (2) undifferentiated carcinoma. 
The materials were fixed in 10% formalin, and embedded 
in paraffin for histochemical and immunohistochemical 
studies. Sections were cut at 4 micron and stained with 
hematoxylin and eosin stain for histological examination.
Anti-PCNA immunostaining 
The number of PCNA positive nuclei in 100 nuclei per 
structural component of differentiated non-keratinizing 
carcinoma type of specimens were stained by indirect 
peroxidase-antiperoxidase (PAP) method for PCNA (Dako 
corp., U. S. A., No. 879; Lot. 121). This antibody was 
diluted 1:50 with PBS pH 7.4. The indirect PAP method 
was performed for the staining of PCNA using Dako 
Universal kit for monoclonal antibody (Dako corp., PAP 
kit K550, Lot. 072-6). 
  The steps involved in the immunoperoxidase procedure 
are the following: (1) Deparaffinize and hydrate in distilled 
water. (2) Treat with hydrogen peroxidase for 5 minutes. 
(3) Wash in Tris buffer pH 7.4 using three cycle changes of 
3 minutes each. (4) Treat with normal serum for 20 
minutes. (5) Treat with blot excess normal serum from 
sections. (6) Treat with primary antibody for 3 hours in 
room temperature. (7) Wash in Tris buffer pH 7.4 using 
three cycle changes of 5 minutes. (8) Treat with second 
antibody for 40 minutes in room temperature. (9) Wash in 
Tris buffer pH 7.4 using three cycle changes of 5 minutes. 
(10) Treat with PAP for 40 minutes in room temperature. 
(11) Wash in Tris buffer pH 7.4 using three cycle changes 
of 5 minutes. (12) Treat with 3, 3-diaminobenzidine tetra-
hydrochloride (DAB) solution with hydrogen peroxidase 
for 5 minutes. (13) Wash in running water. (14) Nuclei 
stain in Mayer's hematoxylin for 2 minutes. (15) Wash in 
running water. (16) Dehydrate, clear, and mount. 
AgNOR staining 
To assess the proliferative activity of these lesions, one-
step silver colloid for NOR was applied and the number of 
AgNOR dots in 100 nuclei per structural component of 
differentiated non-keratinizing carcinoma type of NPC and 
undifferentiated carcinoma type of NPC were counted. The 
AgNORs method was modified as follows: (1) Deparaf-
finize and hydrate in distilled water. (2) Treat with Ag-
NORs solution for 30 minutes at 37 °C incubator. AgNORs 
solution: One volume of 2% gelatin in 1% formic acid 
solution and two volume of 50% silver nitrate solution was 
mixed before using. (3) Wash in warm water using three 
cycle changes. (4) Treat with 0.2% gold chloride solution 
for 5 minutes. (5) Wash in running water. (6) Dehydrate, 
clear, and mount. No counterstain was used. 
Mitotic counting 
The tissue sections were stained with hematoxylin and 
eosin. Mitotic counting was performed in 100 nuclei per 
structural component of differetiated non-keratinizing car-
cinoma type of NPC and undifferetiated carcinoma type of 
NPC.
Results 
Immunostaining for PCNA yielded distinct nuclear label-
ling which was easy to count. The fraction of PCNA 
immunoreactivity was widely distributed in the NPC tis-
sues. By PCNA immunohistochemistry, 28% of differ-
entiated non-keratinizing carcinoma type of NPC (Fig. 1) 
and 18% of undifferentiated carcinoma type of NPC (Fig. 
2) were positively reacted. In all specimens AgNORs were 
clearly visible as black dots of varying size in the nuclei. 
These were arranged into one or more clusters. Most of the 
AgNOR dots in differentiated non-keratinizing carcinoma 
type of NPC and undifferentiated carcinoma type of NPC 
were small and round in shape. The AgNOR dot-size in 
undifferentiated carcinoma type of NPC was larger than 
differentiated non-keratinizing carcinoma type of NPC. 
The mean AgNOR counts for differentiated non-
keratinizing carcinoma type of NPC (Fig. 3) and undiffer-
entiated carcinoma (Fig. 4) were 1.8 and 1.2, respectively. 
The mean mitotic counts for differentiated non-keratinizing
Fig. 1. PCNA positive nuclei are seen in differentiated non-
keratinizing carcinoma tissue of nasopharynx. I mmuno reactivity 
for PCNA, X 400.
Fig. 2. PCNA positive nuclei are detected in undifferentiated 
carcinoma tissue of nasophrynx. Immunoreactivity for PCNA, X 
400.
carcinoma type of NPC and undifferentiated carcinoma 
type of NPC were 3.4 and 2.1, respectively (Figs. 5 and 6). 
Therefore, differentiated non-keratinizing carcinoma type 
of NPC had a higher AgNOR scores than undifferentiated 
type of NPC. The mitotic indeces correlated with both 
ratios of PCNA fraction and the number of AgNOR dots 
count.
Fig. 3. Silver-stained for AgNOR proteins are shown non-
keratinizing carcinoma tissue of nasopharynx. The tumor nuclei 
accumulated one to five AgNOR dots. X 400.
Fig. 5. Mitosis are seen in differentiated non-keratinizing carci-
noma tissue of nasopharynx. Hematoxylin-and eosin stain, X 400.
Fig. 4. Silver-stained for AgNOR proteins are observed in 
undifferentiated carcinoma tissue of nasopharynx. Most of the 
neoplastic nuclei contained one AgNOR dots. X 400.
Fig. 6. Mitosis are detected in undifferentiated carcinoma tissue 
of nasopharynx. Hematoxylin-and-eosin stain, X 400.
Discussion 
One of the aims in diagnostic surgical pathology is the 
identification of morphological markers for malignant 
transformation, and the nucleus and the nucleolus are 
studied in this field. Immunohistochemical detection of cell 
cycle related markers for estimation of tumor growth frac-
tions using paraffin embedded tissue sections would have 
applications in clinical pathology as an in situ histological 
alternative to flow cytometry.3' DNA replication, chro-
mosome condition, and mitosis can be useful markers for 
cellular growth and division. We investigated PCNA, 
AgNORs, and mitotic indeces for proliferative activity in 
NPC obtained from southern China using immunohis-
tochemical and histochemical procedures. There was a 
correlation among PCNA fraction, AgNOR count, and 
mitotic indeces. 
 Proliferating cell nuclear antigen (PCNA) was originally 
detected by Miyachi and co-workers" during experiments 
with autoantibodies in the sera from patients with SLE 
which reacted with nuclei of proliferating cells in normal
human tissues. DNA synthesis and rate of cellular prolif-
eration have been found to be important factors in human 
malignancy. This study shows that monoclonal antibody 
PCNA is a valuable marker for proliferating cells in 
formalin-fixed and paraffin-embedded tissues. The distri-
bution of PCNA in the cell cycle increases through G1, 
peak at the G1/S phase interphase and decreases through 
G2 phase reaching levels which are virtually undetectable 
in M phase and in quiescent cell using immunohis-
tochemical method."' The human PCNA gene has 261 
amino acid polypeptide with a high content of asparate and 
glutamic acid. In most autopsy specimens PCNA immuno-
reactivity was markedly diminished as compared with 
similar surgical specimens. This indicates that PCNA is 
stable under conditions routinely encountered in diagnostic 
surgical pathology and facilitates its potential use as a 
diagnostic proliferation marker.',',', 15, 16.18) High fractions of 
PCNA immunolabelling combined with low mitotic indeces 
were observed in NPC. 
 The AgNOR proteins are defined as markers of "active" 
ribosomal genes.') In cycling cells, the quantity of AgNOR 
proteins increases progessively during the G1 phase. The 
synthesis of AgNOR proteins during G 1 is associated with 
ribosomal chromatin dispersion. These argyrophilic pro-
teins are specifically related to NORs, which are loops of 
ribosomal DNA (rDNA) that transcribe for ribosomal nu-
cleic acid (rRNA) and are involved in the synthesis of the 
site of 18S and 28S rRNA.'°' AgNOR proteins are detected 
by a specific silver staining procedure based on the ability 
of such proteins to reduce silver under acidic conditions. 
Their size and number might reflect cell proliferation and 
malignant transformation. A simple silver colloid staining 
method for NORs has been applied to paraffin sections of 
tumors in studies of oncogenesis. Many investigators have 
reported that enumeration of AgNORs is useful for histo-
logical diagnosis between benign and malignant tumors, 
because the number and distribution pattern of AgNORs 
can be easily detected by light microscopy in paraffin 
embedded tissues.' 5 8 10,14) This study assessed the value of 
AgNOR staining as a potential technique for the estimation 
of cell kinetics in conventional histological sections in 
NPC. Finally, in further investigations, we would like to 
know relationship between prognosis of NPC and markers 
for the activity of cell proliferation.
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